Cartesian Therapeutics, Inc.
RNAC
$6.36
-$0.30-4.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.58M | -35.90M | 15.89M | -17.71M | -10.25M |
| Total Depreciation and Amortization | 608.00K | 606.00K | 589.00K | 1.16M | 486.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.26M | 19.17M | -32.49M | 528.00K | -4.08M |
| Change in Net Operating Assets | -3.00K | 530.00K | -1.51M | -7.08M | 6.85M |
| Cash from Operations | -17.71M | -15.60M | -17.52M | -23.11M | -7.00M |
| Capital Expenditure | -492.00K | -1.29M | -2.60M | -1.08M | -705.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 351.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -492.00K | -1.29M | -2.60M | -1.08M | -354.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.00K | 5.00K | 85.00K | 183.00K | 849.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.00K | -43.00K | -25.00K | -8.21M | -66.00K |
| Cash from Financing | -52.00K | -38.00K | 60.00K | -8.03M | 783.00K |
| Foreign Exchange rate Adjustments | 11.00K | -10.00K | 12.00K | 32.00K | -15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.25M | -16.94M | -20.04M | -32.18M | -6.59M |